Interactions between ovarian hormones and cocaine may underlie gender and estrous cycle differences in cocaine‐induced behavioral and neurochemical alterations. The aim of this study was to further understand how ovarian hormones modulate cocaine‐induced behavioral alterations. Ovariectomized rats received acute or chronic saline or cocaine (15 mg/kg i.p.) administration and were further subdivided into one of four hormone‐treatment conditions: cholesterol (vehicle‐control), estrogen, progesterone, or estrogen+progesterone. Overall, acute and chronic cocaine administration increased all locomotor measurements (total locomotor, ambulatory, and rearing counts). Estrogen administration augmented cocaine‐induced increases in ambulatory and rearing activity. After chronic cocaine administration, rats in the vehicle‐control group developed behavioral tolerance (exhibited by a decrease in activity) in rearing and ambulatory activity. Estrogen replacement not only prevented the development of tolerance in ambulatory and rearing activities, but also enhanced total locomotor activity (sensitization) in response to chronic cocaine. Progesterone treatment did not alter the behavioral responses to acute or chronic cocaine administration. Estrogen+progesterone‐treated animals had higher counts of locomotor activity in response to chronic cocaine than did vehicle‐control or progesterone‐treated rats. In stereotypic behaviors, the different hormonal treatments did not affect activity in cocaine‐ or saline‐treated rats after acute or chronic drug administration. Plasma levels of cocaine did not change after different hormonal treatments. Interestingly, animals' coadministered chronic cocaine and estrogen had higher levels of corticosterone than did nonestrogen cocaine‐treated rats. Thus, it is likely that alterations in HPA activation may underlie the observed behavioral differences. In summary, these data suggest that there are interactions between ovarian hormones and cocaine‐induced behavioral alterations in female rats, and they extend previous results by showing that estrogen and progesterone affect the development of sensitization.
The earliest observations on variations in percentage of salts in saliva with which we are acquainted, are those of Ludwig and Becher, in 1851. They analysed successive portions of saliva, obtained under different conditions, from the submaxillary gland of the Dog. Three experiments were made on the effect of protracted secretion; in two of these the percentage of salts sank in the successive portions of saliva, but in the remaining one, the third and fourth samples of saliva contained a rather higher percentage of salts than the second and first samples. The total amount of saliva collected in this case was 48∙5 grm.
Heidenhain has shown that when saliva is obtained by stimulating the chorda tympani, the percentage of salts in the saliva depends upon the rate of secretion, so that the faster the secretion the higher the percentage of salts is up to a limit of about 0·6 per cent. Werther has come to the same conclusion, but finds that the percentage of salts may be as much as 0·77. Both in Heidenhain’s and in Werther’s experiments there are many exceptions to this rule, attributed by them to variations in the rate of secretion of saliva during the time of collecting any one sample.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.